MSH|^~\&|IGENE|MFT|EPIC|MFT|20251014155942||ORU^R01|ORIE-251014-9|T|2.3PID||9737383214|||LANCASTER^Jaime||19700727|M|||^^^^LA1 1PJORC|RE|LRI-1000152867|||||||||||||||||||Alder Hey^^^^^RBS^^^ODSOBR|1|Acme23469|Gen825750|R185.1^Cystic fibrosis carrier testing^England-GenomicTestDirectory|R|201608030830|201608091650|Variables that Apply to Overall Study: Report Section 1OBX|1|TX|53577-3^Reason for study^LN|1|Patient may be carrier for cystic fibrosis|OBX|2|CWE|51967-8^Genetic disease(s) assessed^LN|1|C0010674^Cystic fibrosis^MedGen-Dis|OBX|3|CWE|51958-7^Transcript reference sequence [Identifier]^LN|1|NM_000492.3^NM_000492.3^RefSeq-TOBX|4|CNE|48018-6^Gene studied^LN|1.a|1884^CFTR^HGNC-Symb|OBX|5|CWE|36908-2^Gene mutations tested^LN|1.a|7105^NM_000492.3(CFTR):c.1521_1523delCTT (p.Phe508delPhe)^ClinVar-V|OBX|6|CWE|36908-2^Gene mutations tested^LN|1.b|7106^NM_000492.3(CFTR):c.1519_1521delATC(p.Ile507del)^ClinVar-V|OBX|7|CWE|36908-2^Gene mutations tested^LN|1.c|7129^NM_000492.3(CFTR):c.3846G>A (p.Trp1282Ter)^ClinVar-V|OBX|8|CWE|36908-2^Gene mutations tested^LN|1.d|38799^NM_000492.3(CFTR):c.489+1G>T^ClinVar-V|OBX|9|CWE|36908-2^Gene mutations tested^LN|1.e|Gly542Ter^Gly542Ter^HGVS.p|OBX|10|CWE|36908-2^Gene mutations tested^LN|1.f|Arg117His^Arg117His^HGVS.p|OBX|11|CWE|36908-2^Gene mutations tested^LN|1.g|711+1G>T^711+1G>T^HGVS.c|OBX|12|CWE|36908-2^Gene mutations tested^LN|1.h|Asn1303Lys(C>A)^Asn1303Lys(C>A)^HGVS.p|OBX|13|CWE|36908-2^Gene mutations tested^LN|1.i|Arg334Trp^Arg334Trp^HGVS.p|OBX|14|CWE|36908-2^Gene mutations tested^LN|1.j|Arg347Pro^Arg347Pro^HGVS.p|OBX|15|CWE|36908-2^Gene mutations tested^LN|1.k|^^^^^^^^the deletion of exons 2-3|OBX|16|CNE|51968-6^Discrete variation analysis overall interpretation^LN|1|LA6576-8^Positive^LN|OBX|17|FT|51969-4^Full narrative report^LN|1|Result SummaryPositive. \.br\\.br\ Result- The following heterozygous sequence change was identified. Amino Acid: p.F508del (Phe508del), DNA change: c.1521_1523delCTT (g.117199646_117199648), Classification: Pathogenic. \.br\\.br\ Interpretation- This result indicates that this individual is a carrier of cystic fibrosis (CF). This interpretation assumes that this individual is not clinically affected with CF. Since a mutation has been identified, genetic testing of at risk family members could be considered. If appropriate, genetic testing should be offered to this individual's reproductive partner to further clarify their risk of having a child with CF. \.br\\.br\ Method- A multiplex PCR based was used to detect 106 mutations, including the 23 mutations specified in the American College of Medical Genetics (ACMG) standards for population based carrier screening...Poly T determination and confirmatory testing of homozygous results are performed as reflex tests when appropriate.|OBX|18|CWE|62374-4^Human reference sequence assembly^LN|1|LA14029-5^GRCh37^LN|OBX|19|NM|82115-7^dbSNP version^LN|1|147|Attributes of Discrete Genetic Variants: Report Section 2OBX|20|CNE|83005-9^Variant Category^LN|2a|LA26801-3^Simple Variant^LN|OBX|21|CNE|81252-9^Discrete genetic variant^LN|2a|7105^NM_000492.3(CFTR):c.1521_1523delCTT (p.Phe508delPhe)^ClinVar-V|OBX|22|CWE|48018-6^Gene studied^LN|2a|1884^CFTR^HGNC-Symb|OBX|23|CWE|51958-7^Transcript RefSeq ID^LN|2a|NM_000492.3^NM_000492.3^RefSeq-T|OBX|24|CWE|41103-3^Transcript DNA Change (cHGVS)^LN|2a|c.1521_1523delCTT^c.1521_1523delCTT^HGVS.c|OBX|25|CWE|48005-3^Amino acid change p.HGVS^LN|2a|p.Phe508delPhe^p.Phe508delPhe^HGVS.p|OBX|26|CWE|48019-4^DNA change type^LN|2a|LA6692-3l^deletion^LN|Genomic specification (HGVS code and VCF-like representation)OBX|27|CWE|48013-7^Genomic reference sequence ID^LN|2a|NG_016465.4:g.98809_98811delCTT^NG_016465.4:g.98809_98811delCTT^RefSeq-G|OBX|28|CWE|81290-9^Genomic DNA change(gHGVS)^LN|2a|NC_000007.13^NC_000007.13^HGVS.g|OBX|29|ST|69547-8^Genomic ref allele^LN|2a|CTT|OBX|30|NR|81254-5^Genomic allele start-end^LN|2a|117199646^117199648|OBX|31|ST|69551-0^Genomic alt allele^LN|2a|-|OBX|32|CNE|81255-2^dbSNP ID^LN|2a|rs113993960^rs113993960^dbSNP|OBX|33|CWE|48001-2^Cytogenetic (chromosome) location^LN|2a|7q31.2^7q31.2^Chrom-Loc|OBX|34|CNE|48002-0^Genomic source class^LN|2a|LA6683-2^Germline^LN|InterpretationsOBX|35|CNE|53037-8^Genetic variation Clinical significance^LN|2a|LA6668-3^Pathogenic^LN|OBX|36|CNE|69548-6^Genomic variant assessment^LN|2a|LA9633-4^Present^LN|OBX|37|CWE|81259-4^Probable associated phenotype^LN|2a|R185^Cystic fibrosis^GenomicClinicalIndication|Allelic state/phase informationOBX|38|CNE|53034-5^Allelic state^LN|2a|LA6706-1^Heterozygous^LN|